AGÕæÈ˹ٷ½

STOCK TITAN

[FWP] Goldman Sachs Group Inc. Free Writing Prospectus

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

Franklin Financial Services Corporation (FRAF) filed a Form 4 disclosing that director Daniel J. Fisher acquired 313 common shares on 06/23/2025 at an implied price of $34.60 per share, totaling roughly $10.8 thousand. The shares were issued in lieu of cash compensation for a portion of Fisher’s board fees. Following the transaction, Fisher directly owns 29,276 shares, a figure that includes previously reported unvested restricted stock units. No derivative securities were involved.

The filing represents a routine compensation-related share issuance rather than an open-market purchase, but it still modestly increases insider equity alignment without altering control dynamics or signaling material changes to FRAF’s capital structure.

Franklin Financial Services Corporation (FRAF) ha presentato un Modulo 4 che rivela che il direttore Daniel J. Fisher ha acquisito 313 azioni ordinarie il 23/06/2025 a un prezzo implicito di 34,60 $ per azione, per un valore totale di circa 10,8 mila $. Le azioni sono state emesse in sostituzione della compensazione in contanti per una parte delle sue commissioni da membro del consiglio. Dopo l’operazione, Fisher detiene direttamente 29.276 azioni, cifra che include unità azionarie ristrette non ancora maturate precedentemente segnalate. Non sono stati coinvolti strumenti derivati.

La comunicazione rappresenta un’emissione di azioni legata alla compensazione ordinaria piuttosto che un acquisto sul mercato aperto, ma incrementa comunque modestamente l’allineamento patrimoniale degli insider senza alterare la dinamica di controllo né segnalare cambiamenti significativi nella struttura patrimoniale di FRAF.

Franklin Financial Services Corporation (FRAF) presentó un Formulario 4 que revela que el director Daniel J. Fisher ²¹»å±ç³Ü¾±°ù¾±Ã³ 313 acciones ordinarias el 23/06/2025 a un precio implícito de $34.60 por acción, por un total aproximado de $10.8 mil. Las acciones fueron emitidas en lugar de la compensación en efectivo por una parte de las tarifas de Fisher como miembro del consejo. Tras la transacción, Fisher posee directamente 29,276 acciones, cifra que incluye unidades restringidas de acciones no devengadas previamente reportadas. No se involucraron valores derivados.

La presentación representa una emisión rutinaria de acciones relacionada con la compensación en lugar de una compra en el mercado abierto, pero aún así aumenta modestamente la alineación patrimonial de los insiders sin alterar la dinámica de control ni señalar cambios materiales en la estructura de capital de FRAF.

Franklin Financial Services Corporation(FRAF)ëŠ� ì´ì‚¬ Daniel J. Fisherê°€ 2025ë…� 6ì›� 23ì¼ì— 313ì£�ì� 보통주를 주당 $34.60ì� 암시ì � 가격으ë¡� ì•� $10,800 ìƒë‹¹ì� ì·¨ë“했다ê³� 신고하는 Form 4ë¥� 제출했습니다. ì� 주ì‹ë“¤ì€ Fisherì� ì´ì‚¬íš� 수수ë£� ì¼ë¶€ì—� 대í•� 현금 ë³´ìƒ ëŒ€ì‹� 발행ë˜ì—ˆìŠµë‹ˆë‹�. 거래 í›� FisherëŠ� ì´ì „ì—� ë³´ê³ ë� 미확ì � 제한 ì£¼ì‹ ë‹¨ìœ„ë¥� í¬í•¨í•˜ì—¬ ì§ì ‘ 29,276ì£�ë¥� 보유하게 ë©ë‹ˆë‹�. íŒŒìƒ ì¦ê¶Œì€ í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ ì‹ ê³ ëŠ� 공개 시장ì—서ì� 매수가 아닌 ë³´ìƒ ê´€ë � ì£¼ì‹ ë°œí–‰ì� ì¼í™˜ìœ¼ë¡œ, ë‚´ë¶€ìžì˜ ì§€ë¶� ì •ë ¬ì� ì†Œí­ ì¦ê°€ì‹œí‚¤ì§€ë§� ì§€ë°� 구조 변화나 FRAFì� ìžë³¸ 구조ì—� 중대í•� 변화를 나타내지ëŠ� 않습니다.

Franklin Financial Services Corporation (FRAF) a déposé un formulaire 4 révélant que le directeur Daniel J. Fisher a acquis 313 actions ordinaires le 23/06/2025 à un prix implicite de 34,60 $ par action, pour un total d’environ 10,8 milliers de dollars. Les actions ont été émises en lieu et place d’une rémunération en espèces pour une partie des honoraires de Fisher au conseil d’administration. Après la transaction, Fisher détient directement 29 276 actions, un chiffre qui inclut des unités d’actions restreintes non acquises précédemment déclarées. Aucun titre dérivé n’a été impliqué.

Le dépôt représente une émission d’actions liée à la rémunération de routine plutôt qu’un achat sur le marché ouvert, mais augmente néanmoins modestement l’alignement des intérêts des initiés sans modifier la dynamique de contrôle ni signaler de changements majeurs dans la structure du capital de FRAF.

Die Franklin Financial Services Corporation (FRAF) reichte ein Formular 4 ein, das offenlegt, dass der Direktor Daniel J. Fisher am 23.06.2025 313 Stammaktien zu einem impliziten Preis von 34,60 $ pro Aktie erworben hat, was insgesamt etwa 10,8 Tausend $ entspricht. Die Aktien wurden anstelle einer Barvergütung für einen Teil von Fishers Vorstandsvergütung ausgegeben. Nach der Transaktion besitzt Fisher direkt 29.276 Aktien, eine Zahl, die zuvor gemeldete unverfallbare Restricted Stock Units einschließt. Es waren keine Derivate beteiligt.

Die Meldung stellt eine routinemäßige, vergütungsbezogene Aktienausgabe dar und keinen Kauf am offenen Markt, erhöht jedoch dennoch leicht die Eigenkapitalausrichtung der Insider, ohne die Kontrollverhältnisse zu verändern oder wesentliche Änderungen an der Kapitalstruktur von FRAF anzudeuten.

Positive
  • Director increases direct share ownership, modestly aligning board interests with shareholders.
  • Equity-for-fees structure conserves issuer cash while maintaining compensation value.
Negative
  • Transaction size is immaterial (~$10.8k) and unlikely to influence market perception.
  • Not an open-market purchase; therefore, provides limited incremental confidence signal compared with voluntary buys.

Insights

TL;DR: Minor director stock-for-fees grant; immaterial to valuation, marginally positive for alignment.

The acquisition is worth about $10.8k—trivial against FRAF’s market capitalization. Because the shares replace cash, there is no incremental cash outlay by the insider, limiting the usual bullish signal from direct open-market buys. Nonetheless, the grant raises Fisher’s stake to 29,276 shares, strengthening board-shareholder alignment at negligible dilution. From a valuation or earnings standpoint, the event is not impactful; investors may view it as neutral-to-slightly positive sentiment.

TL;DR: Routine equity compensation improves alignment; governance stance unchanged.

Paying a portion of director fees in stock is a common governance practice that encourages long-term oversight focus. The absence of derivative activity and the direct holding form reduce complexity and potential conflict. Because the share count is de minimis relative to outstanding shares, voting power shift is immaterial. Overall effect on governance quality is positive but not materially impactful to shareholders.

Franklin Financial Services Corporation (FRAF) ha presentato un Modulo 4 che rivela che il direttore Daniel J. Fisher ha acquisito 313 azioni ordinarie il 23/06/2025 a un prezzo implicito di 34,60 $ per azione, per un valore totale di circa 10,8 mila $. Le azioni sono state emesse in sostituzione della compensazione in contanti per una parte delle sue commissioni da membro del consiglio. Dopo l’operazione, Fisher detiene direttamente 29.276 azioni, cifra che include unità azionarie ristrette non ancora maturate precedentemente segnalate. Non sono stati coinvolti strumenti derivati.

La comunicazione rappresenta un’emissione di azioni legata alla compensazione ordinaria piuttosto che un acquisto sul mercato aperto, ma incrementa comunque modestamente l’allineamento patrimoniale degli insider senza alterare la dinamica di controllo né segnalare cambiamenti significativi nella struttura patrimoniale di FRAF.

Franklin Financial Services Corporation (FRAF) presentó un Formulario 4 que revela que el director Daniel J. Fisher ²¹»å±ç³Ü¾±°ù¾±Ã³ 313 acciones ordinarias el 23/06/2025 a un precio implícito de $34.60 por acción, por un total aproximado de $10.8 mil. Las acciones fueron emitidas en lugar de la compensación en efectivo por una parte de las tarifas de Fisher como miembro del consejo. Tras la transacción, Fisher posee directamente 29,276 acciones, cifra que incluye unidades restringidas de acciones no devengadas previamente reportadas. No se involucraron valores derivados.

La presentación representa una emisión rutinaria de acciones relacionada con la compensación en lugar de una compra en el mercado abierto, pero aún así aumenta modestamente la alineación patrimonial de los insiders sin alterar la dinámica de control ni señalar cambios materiales en la estructura de capital de FRAF.

Franklin Financial Services Corporation(FRAF)ëŠ� ì´ì‚¬ Daniel J. Fisherê°€ 2025ë…� 6ì›� 23ì¼ì— 313ì£�ì� 보통주를 주당 $34.60ì� 암시ì � 가격으ë¡� ì•� $10,800 ìƒë‹¹ì� ì·¨ë“했다ê³� 신고하는 Form 4ë¥� 제출했습니다. ì� 주ì‹ë“¤ì€ Fisherì� ì´ì‚¬íš� 수수ë£� ì¼ë¶€ì—� 대í•� 현금 ë³´ìƒ ëŒ€ì‹� 발행ë˜ì—ˆìŠµë‹ˆë‹�. 거래 í›� FisherëŠ� ì´ì „ì—� ë³´ê³ ë� 미확ì � 제한 ì£¼ì‹ ë‹¨ìœ„ë¥� í¬í•¨í•˜ì—¬ ì§ì ‘ 29,276ì£�ë¥� 보유하게 ë©ë‹ˆë‹�. íŒŒìƒ ì¦ê¶Œì€ í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ ì‹ ê³ ëŠ� 공개 시장ì—서ì� 매수가 아닌 ë³´ìƒ ê´€ë � ì£¼ì‹ ë°œí–‰ì� ì¼í™˜ìœ¼ë¡œ, ë‚´ë¶€ìžì˜ ì§€ë¶� ì •ë ¬ì� ì†Œí­ ì¦ê°€ì‹œí‚¤ì§€ë§� ì§€ë°� 구조 변화나 FRAFì� ìžë³¸ 구조ì—� 중대í•� 변화를 나타내지ëŠ� 않습니다.

Franklin Financial Services Corporation (FRAF) a déposé un formulaire 4 révélant que le directeur Daniel J. Fisher a acquis 313 actions ordinaires le 23/06/2025 à un prix implicite de 34,60 $ par action, pour un total d’environ 10,8 milliers de dollars. Les actions ont été émises en lieu et place d’une rémunération en espèces pour une partie des honoraires de Fisher au conseil d’administration. Après la transaction, Fisher détient directement 29 276 actions, un chiffre qui inclut des unités d’actions restreintes non acquises précédemment déclarées. Aucun titre dérivé n’a été impliqué.

Le dépôt représente une émission d’actions liée à la rémunération de routine plutôt qu’un achat sur le marché ouvert, mais augmente néanmoins modestement l’alignement des intérêts des initiés sans modifier la dynamique de contrôle ni signaler de changements majeurs dans la structure du capital de FRAF.

Die Franklin Financial Services Corporation (FRAF) reichte ein Formular 4 ein, das offenlegt, dass der Direktor Daniel J. Fisher am 23.06.2025 313 Stammaktien zu einem impliziten Preis von 34,60 $ pro Aktie erworben hat, was insgesamt etwa 10,8 Tausend $ entspricht. Die Aktien wurden anstelle einer Barvergütung für einen Teil von Fishers Vorstandsvergütung ausgegeben. Nach der Transaktion besitzt Fisher direkt 29.276 Aktien, eine Zahl, die zuvor gemeldete unverfallbare Restricted Stock Units einschließt. Es waren keine Derivate beteiligt.

Die Meldung stellt eine routinemäßige, vergütungsbezogene Aktienausgabe dar und keinen Kauf am offenen Markt, erhöht jedoch dennoch leicht die Eigenkapitalausrichtung der Insider, ohne die Kontrollverhältnisse zu verändern oder wesentliche Änderungen an der Kapitalstruktur von FRAF anzudeuten.

Free Writing Prospectus pursuant to Rule 433 dated June 30, 2025

Registration Statement No. 333-284538

 

 

 

img82009282_0.jpg

Buffered Index-Linked Notes

 

 

 

OVERVIEW

This document relates to two separate offerings. Each note is linked to the performance of one underlier (either the S&P 500® Index or the Russell 2000® Index). Each note has its own terms (set forth in the table below), which will be set on the trade date.

The notes do not bear interest. The amount that you will be paid on your notes on the stated maturity date is based on the performance of the applicable underlier as measured from the trade date to and including the determination date.

If the final underlier level of the applicable underlier (the closing level of such underlier on the determination date) is greater than its initial underlier level (set on the trade date and will be an intra-day level or the closing level of such index on the trade date), the return on your notes will be positive and will equal the applicable participation rate times the underlier return of the applicable underlier (the quotient of (i) the final underlier level minus the initial underlier level divided by (ii) the initial underlier level, expressed as a percentage), subject to the applicable maximum settlement amount. If the final underlier level of the applicable underlier is greater than its initial underlier level, you will not receive more than the maximum settlement amount, regardless of how much the final underlier level of the applicable underlier increases as compared to its initial underlier level.

If the final underlier level of the applicable underlier is equal to or less than its initial underlier level but greater than or equal to its applicable buffer level, you will receive the face amount of your notes. If the final underlier level of the applicable underlier is less than its applicable buffer level, the return on your notes will be negative and will equal the underlier return of the applicable underlier plus the applicable buffer amount. You could lose a significant portion of the face amount of your notes.

At maturity, for each $1,000 face amount of your notes, you will receive an amount in cash equal to:

if the final underlier level of the applicable underlier is greater than its initial underlier level, the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) the applicable participation rate times (c) the underlier return of the applicable underlier, subject to the applicable maximum settlement amount;
if the final underlier level of the applicable underlier is equal to or less than its initial underlier level, but greater than or equal to its applicable buffer level, $1,000; or
if the final underlier level of the applicable underlier is less than its applicable buffer level, the sum of (i) $1,000 plus (ii) the product of (a) the sum of the underlier return of the applicable underlier plus the applicable buffer amount times (b) $1,000.

You should read the accompanying preliminary pricing supplement dated June 27, 2025, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc.

The notes are unsecured notes issued by GS Finance Corp. and guaranteed by The Goldman Sachs Group, Inc. The key terms specific to each tranche of notes are set forth on the following page(s). Please carefully review the key terms relating to the particular tranche(s) of notes that you are purchasing. Each tranche of notes has its own underlier and terms.

 

This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in any notes without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the applicable underlier, the terms of the notes and certain risks.


 

 

Key Terms For Notes Linked to the S&P 500® Index

CUSIP / ISIN:

40058JK87 / US40058JK877

Underlier:

the S&P 500® Index (current Bloomberg symbol: “SPX Index”)

Cap level:

at least 156% of the initial underlier level

Maximum settlement amount:

at least $1,560

Participation rate:

100%

Buffer level:

85% of the initial underlier level

Buffer amount:

15%

Trade date:

expected to be July 28, 2025

Settlement date:

expected to be July 31, 2025

Determination date:

expected to be July 29, 2030

Stated maturity date:

expected to be August 1, 2030

Estimated value range:

$885 to $925 (which is less than the original issue price; see accompanying preliminary pricing supplement)

 

img82009282_1.jpg

Hypothetical Final Underlier Level
(as a % of the Initial Underlier Level)

Hypothetical Payment Amount at Maturity*
(as a % of Face Amount)

200.000%

156.000%

190.000%

156.000%

180.000%

156.000%

175.000%

156.000%

156.000%

156.000%

140.000%

140.000%

120.000%

120.000%

100.000%

100.000%

97.000%

100.000%

95.000%

100.000%

92.000%

100.000%

85.000%

100.000%

70.000%

85.000%

50.000%

65.000%

25.000%

40.000%

0.000%

15.000%

* assumes a cap level of 156% of the initial underlier level

 

Key Terms For Notes Linked to the Russell 2000® Index

CUSIP / ISIN:

40058JKA2 / US40058JKA24

Underlier:

the Russell 2000® Index (current Bloomberg symbol: “RTY Index”)

Cap level:

at least 169.5% of the initial underlier level

Maximum settlement amount:

at least $1,695

Participation rate:

100%

Buffer level:

85% of the initial underlier level

Buffer amount:

15%

Trade date:

expected to be July 28, 2025

Settlement date:

expected to be July 31, 2025

Determination date:

expected to be July 29, 2030

Stated maturity date:

expected to be August 1, 2030

Estimated value range:

$885 to $925 (which is less than the original issue price; see accompanying preliminary pricing supplement)

 

img82009282_2.jpg

Hypothetical Final Underlier Level
(as a % of the Initial Underlier Level)

Hypothetical Payment Amount at Maturity**
(as a % of Face Amount)

200.000%

169.500%

195.000%

169.500%

193.000%

169.500%

192.000%

169.500%

169.500%

169.500%

140.000%

140.000%

120.000%

120.000%

100.000%

100.000%

97.000%

100.000%

95.000%

100.000%

92.000%

100.000%

85.000%

100.000%

70.000%

85.000%

50.000%

65.000%

25.000%

40.000%

0.000%

15.000%

** assumes a cap level of 169.5% of the initial underlier level

This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in any notes without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the applicable underlier, the terms of the notes and certain risks.

2


 

 

 

About Your Notes

GS Finance Corp. and The Goldman Sachs Group, Inc. have filed a registration statement (including a prospectus, as supplemented by the prospectus supplement, underlier supplement no. 45, general terms supplement no. 17,741 and preliminary pricing supplement listed below) with the Securities and Exchange Commission (SEC) for the offerings to which this communication relates. Before you invest, you should read the prospectus, prospectus supplement, underlier supplement no. 45, general terms supplement no. 17,741 and preliminary pricing supplement, and any other documents relating to these offerings that GS Finance Corp. and The Goldman Sachs Group, Inc. have filed with the SEC for more complete information about us and these offerings. You may get these documents without cost by visiting EDGAR on the SEC web site at sec.gov. Alternatively, we will arrange to send you the prospectus, prospectus supplement, underlier supplement no. 45, general terms supplement no. 17,741 and preliminary pricing supplement if you so request by calling (212) 357-4612.

The notes are part of the Medium-Term Notes, Series F program of GS Finance Corp. and are fully and unconditionally guaranteed by The Goldman Sachs Group, Inc. This document should be read in conjunction with the following:

Preliminary pricing supplement dated June 27, 2025
General terms supplement no. 17,741 dated February 14, 2025
Underlier supplement no. 45 dated June 23, 2025
Prospectus supplement dated February 14, 2025
Prospectus dated February 14, 2025

This document relates to two separate offerings of notes. Each note is linked to one, and only one, underlier. You may participate in any of the two offerings or, at your election, in both of the offerings. This document does not, however, allow you to purchase a note linked to a basket of some or all of the underliers.

 

This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in any notes without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the applicable underlier, the terms of the notes and certain risks.

3


 

 

RISK FACTORS

An investment in the notes is subject to risks. Many of the risks are described in the accompanying preliminary pricing supplement, accompanying general terms supplement no. 17,741, accompanying underlier supplement no. 45, accompanying prospectus supplement and accompanying prospectus. Below we have provided a list of certain risk factors discussed in such documents. In addition to the below, you should read in full “Additional Risk Factors Specific to Your Notes” in the accompanying preliminary pricing supplement, “Additional Risk Factors Specific to the Notes” in the accompanying general terms supplement no. 17,741 and “Additional Risk Factors Specific to the Securities” in the accompanying underlier supplement no. 45, as well as the risks and considerations described in the accompanying prospectus supplement and accompanying prospectus.

The following risk factors are discussed in greater detail in the accompanying preliminary pricing supplement:

 

Risks Relating to Each Note

Risks Related to Structure, Valuation and Secondary Market Sales

The Estimated Value of Your Notes At the Time the Terms of Your Notes Are Set On the Trade Date (as Determined By Reference to Pricing Models Used By GS&Co.) Is Less Than the Original Issue Price Of Your Notes
The Notes Are Subject to the Credit Risk of the Issuer and the Guarantor
The Amount Payable on Your Notes Is Not Linked to the Level of the Underlier at Any Time Other Than the Determination Date
You May Lose a Substantial Portion of Your Investment in the Notes
Your Notes Do Not Bear Interest
The Market Value of Your Notes May Be Influenced by Many Unpredictable Factors

 

The Potential for the Value of Your Notes to Increase Will Be Limited
You Have No Shareholder Rights or Rights to Receive Any Underlier Stock
We May Sell an Additional Aggregate Face Amount of the Notes at a Different Issue Price
If You Purchase Your Notes at a Premium to Face Amount, the Return on Your Investment Will Be Lower Than the Return on Notes Purchased at Face Amount and the Impact of Certain Key Terms of the Notes Will Be Negatively Affected

Risks Related to Tax

The Tax Consequences of an Investment in Your Notes Are Uncertain
Foreign Account Tax Compliance Act (FATCA) Withholding May Apply to Payments on Your Notes, Including as a Result of the Failure of the Bank or Broker Through Which You Hold the Notes to Provide Information to Tax Authorities

The following risk factors are discussed in greater detail in the accompanying general terms supplement no. 17,741:

 

Risks Related to Structure, Valuation and Secondary Market Sales

If the Value of an Underlier Changes, the Market Value of Your Notes May Not Change in the Same Manner
The Return on Your Notes Will Not Reflect Any Dividends Paid on Any Underlier, or Any Underlier Stock, as Applicable
Past Performance is No Guide to Future Performance
Your Notes May Not Have an Active Trading Market
The Calculation Agent Will Have the Authority to Make Determinations That Could Affect the Market Value of Your Notes, When Your Notes Mature and the Amount, If Any, Payable on Your Notes
The Calculation Agent Can Postpone the Determination Date, Averaging Date, Call Observation Date or Coupon Observation Date If a Market Disruption Event or Non-Trading Day Occurs or Is Continuing

Risks Related to Conflicts of Interest

Other Investors in the Notes May Not Have the Same Interests as You

 

Hedging Activities by Goldman Sachs or Our Distributors May Negatively Impact Investors in the Notes and Cause Our Interests and Those of Our Clients and Counterparties to be Contrary to Those of Investors in the Notes
Goldman Sachs’ Trading and Investment Activities for its Own Account or for its Clients Could Negatively Impact Investors in the Notes
Goldman Sachs’ Market-Making Activities Could Negatively Impact Investors in the Notes
You Should Expect That Goldman Sachs Personnel Will Take Research Positions, or Otherwise Make Recommendations, Provide Investment Advice or Market Color or Encourage Trading Strategies That Might Negatively Impact Investors in the Notes
Goldman Sachs Regularly Provides Services to, or Otherwise Has Business Relationships with, a Broad Client Base, Which May Include the Sponsors of the Underlier or Underliers or Constituent Indices, As Applicable, the Investment Advisors of the Underlier or Underliers, As Applicable, or the Issuers of the Underlier or the Underlier Stocks or Other Entities That Are Involved in the Transaction

This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in any notes without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the applicable underlier, the terms of the notes and certain risks.

4


 

The Offering of the Notes May Reduce an Existing Exposure of Goldman Sachs or Facilitate a Transaction or Position That Serves the Objectives of Goldman Sachs or Other Parties

 

Risks Related to Tax

Certain Considerations for Insurance Companies and Employee Benefit Plans

The following risk factors are discussed in greater detail in the accompanying underlier supplement no. 45:

 

Additional Risks Relating to Securities Linked to Underliers that are Equity Indices

If Your Securities Are Linked to an Equity Index, the Policies of the Applicable Underlier Sponsor and Changes that Affect Such Underlier, or the Constituent Indices or Underlier Stocks Comprising Such Underlier, Could Affect the Amount Payable on Your Securities and Their Market Value

 

If Your Securities Are Linked to an Equity Index, Except to the Extent The Goldman Sachs Group, Inc. Is One of the Companies Whose Common Stock Comprises the Applicable Underlier, and Except to the Extent That We or Our Affiliates May Currently or in the Future Own Securities of, or Engage in Business With, the Applicable Underlier Sponsor or the Issuers of the Underlier Stocks, There Is No Affiliation Between the Issuers of the Underlier Stocks or Such Underlier Sponsor and Us

The following risk factors are discussed in greater detail in the accompanying prospectus supplement:

 

The Return on Indexed Notes May Be Below the Return on Similar Securities
The Issuer of a Security or Currency That Serves as an Index Could Take Actions That May Adversely Affect an Indexed Note
An Indexed Note May Be Linked to a Volatile Index, Which May Adversely Affect Your Investment

 

An Index to Which a Note Is Linked Could Be Changed or Become Unavailable
We May Engage in Hedging Activities that Could Adversely Affect an Indexed Note
Information About an Index or Indices May Not Be Indicative of Future Performance
We May Have Conflicts of Interest Regarding an Indexed Note

The following risk factors are discussed in greater detail in the accompanying prospectus:

 

Risks Relating to Regulatory Resolution Strategies and Long-Term Debt Requirements

The application of regulatory resolution strategies could increase the risk of loss for holders of our securities in the event of the resolution of Group Inc.

 

The application of Group Inc.’s proposed resolution strategy could result in greater losses for Group Inc.’s security holders.

 

For details about the license agreement between the applicable underlier sponsor and the issuer, see “The Underliers — S&P 500® Index” and “The Underliers ─ Russell 2000® Index” on pages S-127 and S-88 of the accompanying underlier supplement no. 45, respectively.

This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in any notes without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the applicable underlier, the terms of the notes and certain risks.

5


FAQ

How many FRAF shares did director Daniel J. Fisher acquire?

He received 313 common shares on 06/23/2025.

What was the implied price for the shares acquired by the FRAF director?

The shares were valued at approximately $34.60 each.

What is Daniel J. Fisher’s total FRAF shareholding after the transaction?

Following the grant, he directly owns 29,276 shares, including unvested RSUs.

Why were the shares issued to the FRAF director?

They were issued in lieu of cash for a portion of the director’s fees.

Were any derivative securities involved in this Form 4 filing for FRAF?

No, no derivative securities were reported.
Goldman Sachs Group Inc

NYSE:GS

GS Rankings

GS Latest News

GS Latest SEC Filings

GS Stock Data

224.22B
305.04M
0.55%
74.41%
1.55%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
NEW YORK